MedTrace Logo

Colon Cancer Treatment Decisions and Recurrence Predicting

NCT02997241 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2016-12-20

No results posted yet for this study

Summary

The purpose of the study is to determine the relationship between change of gene copies and recurrence，and the overall survival at 5 years after chemotherapy based on clinical prognosis compared to Oncocare detection prognosis.

Conditions

  • Colonic Neoplasms

Interventions

BIOLOGICAL

OncoCare

Personalized monitoring

DRUG

chemotherapy for colorectal carcinoma

chemotherapy for colorectal carcinoma

Sponsors & Collaborators

  • Chinese PLA General Hospital

    collaborator OTHER

  • MyGenostics Inc., Beijing

    lead INDUSTRY

Principal Investigators

  • Wentong Xu, A.P. · Chinese PLA General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-12-31
Completion
2022-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02997241 on ClinicalTrials.gov